Mendelspod
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Quantum Scale: A New Era for Single-Cell Analysis with Giovanna Prout
On today’s episode of Mendelspod, Theral sits down with Giovanna Prout, CEO of Scale Biosciences, to explore a how the company is achieving new orders…
May 8
•
Theral Timpson
2
Share this post
Copy link
Facebook
Email
Notes
More
36:33
Building Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of Science
What if you could step inside a molecule? On today’s episode of Mendelspod, we talk with Steve McCloskey, founder and CEO of Nanome, the company…
May 1
•
Theral Timpson
1
Share this post
Copy link
Facebook
Email
Notes
More
42:06
April 2025
Beyond the $100 Genome--the Everyday Sequencing Revolution You Missed: Mark Budde, Plasmidsaurus
Wait! What? Sequencing as a service?That was the reaction when Mark Budde first set out to upend a basic ritual in molecular biology—confirmation Sanger…
Apr 29
•
Theral Timpson
Share this post
Copy link
Facebook
Email
Notes
More
36:40
What Next for LDTs? A Conversation with Sarah Overton of Velsera
Just weeks before the FDA’s sweeping rule to regulate laboratory-developed tests (LDTs) was set to take effect, a federal court struck it down.
Apr 22
•
Theral Timpson
2
Share this post
Copy link
Facebook
Email
Notes
More
37:49
AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
In today’s show, Theral is joined by Chris Petersen, Chief Technology Officer at Scientist.com, a company sometimes called the "Amazon for…
Apr 17
•
Theral Timpson
3
Share this post
Copy link
Facebook
Email
Notes
More
26:46
We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's
In today’s program, we continue our series on disease subtyping with Dr. Jeffery Klco, a pediatric pathologist and researcher at St. Jude Children’s…
Apr 15
•
Theral Timpson
Share this post
Copy link
Facebook
Email
Notes
More
25:24
Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research
Dr. Aaron Viny, oncologist and researcher at Columbia University, begins today’s conversation with a personal milestone—he’s now been leukemia-free for…
Apr 10
•
Theral Timpson
7
Share this post
Copy link
Facebook
Email
Notes
More
40:40
Toward Disease Sub-typing with Ben Busby, DNAnexus
We’re happy to welcome back Ben Busby, Principal Scientist at DNAnexus, to dive deeper into the evolving world of disease subtyping and multi-omic data…
Apr 3
•
Theral Timpson
5
Share this post
Copy link
Facebook
Email
Notes
More
29:32
Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers
John Cumbers, founder of SynBioBeta, joins Theral for our annual look ahead at the field of synthetic biology and the upcoming SynBioBeta 2025…
Apr 1
•
Theral Timpson
4
Share this post
Copy link
Facebook
Email
Notes
More
37:35
March 2025
Beyond the Parts List: Chris Mason and Simon Fredriksson on Mapping the Immune System in Space and Cancer with Cell Surface Proteomics
In this episode of Mendelspod, host Theral Timpson is joined by returning guest Chris Mason of Weill Cornell Medicine and Simon Fredriksson, CEO of…
Mar 27
•
Theral Timpson
6
Share this post
Copy link
Facebook
Email
Notes
More
24:00
DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024
In our last episode, we explored the growing shift from genomics to multi-omics.
Mar 20
•
Theral Timpson
4
Share this post
Copy link
Facebook
Email
Notes
More
38:50
A New Sequencing Technology Has Entered the World: Keith Robison Reviews AGBT and New Tech in our Annual Sequencing--er, Multi-Omics Show
It’s time for our annual deep dive into sequencing—no, wait—multi-omics! Back on the show is our resident sequencing guru, Keith Robison, scientist at…
Mar 13
•
Theral Timpson
5
Share this post
Copy link
Facebook
Email
Notes
More
41:57
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
